Michael Bauer – CEO & Board Member, Cellestia
Dr Michael Bauer, a Novartis early development veteran, now serves as CEO of Basel-based Cellestia. Here, Bauer explains why Cellestia’s unique…
Fabian Gerber – Senior Relationship Manager Primary…
Fabian Gerber of SIX Swiss Exchange, Switzerland's principal stock exchange, outlines the importance of life sciences companies to the exchange,…
Josua Jordi – CEO & Co-Founder, EraCal Therapeutics
Josua Jordi of Swiss biotech EraCal explains the company’s technology platform, their work with zebrafish larvae to find a biologic mechanism to…
René P Buholzer – CEO, Interpharma, Switzerland
Interpharma’s Dr René P. Buholzer highlights the key lessons that Switzerland’s innovative pharmaceutical industry has taken from the COVID-19…
Katrien de Vos – Country President, AstraZeneca Switzerland
AstraZeneca's recently arrived Switzerland country president, Katrien de Vos, gives her first impressions of the Swiss market and how she hopes to…
Susanne Caspar – CEO, Linnea
Susanne Caspar, CEO at Swiss natural API producer Linnea, talks about her first few months in the company, the pharmaceutical industry’s growing…
Luis Iglesias – President & Head of EMEA, Santen
Santen is a leading multinational company that specializes in ophthalmology. President and Head for Europe, Middle East and Africa (EMEA) Luis…
Antonio Francesco Di Naro – President & Founder,…
Swiss-headquartered ADIENNE has made recent headlines after being announced as the first European company to manufacture Russia’s Sputnik V COVID-19…
Georg Boonen – CEO, Max Zeller
Georg Boonen, CEO of Switzerland’s leading phytopharmaceutical player Max Zeller, discusses the company’s expanded market position at home and…
Vincent Gruntz – General Manager Oncology, Novartis Pharma…
Vincent Gruntz looks at the market dynamics for oncology in Switzerland, where an increasingly cost-conscious approach is being taken to reimbursement…
Katharina Gasser – Managing Director, Biogen Switzerland
Biogen Switzerland’s Dr med Katharina Gasser outlines how her affiliate navigated the COVID-19 pandemic from an organisational and communication…
Michael Altorfer – CEO, Swiss Biotech Association
Michael Altorfer, CEO of the Swiss Biotech Association, a membership organisation representing the interests of the Swiss biotech industry, discusses…